[ESPR] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -30.32%
YoY- -26.60%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 137,735 24,329 18,836 7,978 1,840 145,419 0 -
PBT 61,022 -61,719 -56,731 -90,935 -78,249 87,379 -46,130 -
Tax -41 27,501 13,742 8,139 4,539 0 0 -
NP 61,022 -89,220 -70,473 -90,935 -78,249 87,379 -46,130 -
Tax Rate 0.07% - - - - 0.00% - -
Total Cost 76,713 113,549 89,309 98,913 80,089 58,040 46,130 8.83%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 44.30 -366.72 -374.14 -1,139.82 -4,252.66 60.09 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS 0.36 -1.14 -1.16 -3.50 -2.84 3.26 -1.73 -
EPS Diluted 0.34 -1.14 -1.16 -3.50 -2.84 3.07 -1.73 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.